161 related articles for article (PubMed ID: 27561180)
1. Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin-4-expressing pancreatic cancer cells.
Awano M; Fujiyuki T; Shoji K; Amagai Y; Murakami Y; Furukawa Y; Sato H; Yoneda M; Kai C
Cancer Sci; 2016 Nov; 107(11):1647-1652. PubMed ID: 27561180
[TBL] [Abstract][Full Text] [Related]
2. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
[TBL] [Abstract][Full Text] [Related]
3. A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells.
Fujiyuki T; Yoneda M; Amagai Y; Obayashi K; Ikeda F; Shoji K; Murakami Y; Sato H; Kai C
Oncotarget; 2015 Sep; 6(28):24895-903. PubMed ID: 26317644
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor activity of a recombinant measles virus against canine lung cancer cells.
Tamura K; Fujiyuki T; Moritoh K; Akimoto H; Iizuka K; Sato H; Asano K; Yoneda M; Kai C
Sci Rep; 2023 Oct; 13(1):18168. PubMed ID: 37875555
[TBL] [Abstract][Full Text] [Related]
5. Development of new therapy for canine mammary cancer with recombinant measles virus.
Shoji K; Yoneda M; Fujiyuki T; Amagai Y; Tanaka A; Matsuda A; Ogihara K; Naya Y; Ikeda F; Matsuda H; Sato H; Kai C
Mol Ther Oncolytics; 2016; 3():15022. PubMed ID: 27119113
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells.
Iizuka K; Shoji K; Fujiyuki T; Moritoh K; Tamura K; Yoshida A; Sato H; Yoneda M; Asano K; Kai C
Res Vet Sci; 2020 Dec; 133():313-317. PubMed ID: 33183781
[TBL] [Abstract][Full Text] [Related]
7. Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy.
Fujiyuki T; Amagai Y; Shoji K; Kuraishi T; Sugai A; Awano M; Sato H; Hattori S; Yoneda M; Kai C
Mol Ther Oncolytics; 2020 Dec; 19():127-135. PubMed ID: 33145396
[TBL] [Abstract][Full Text] [Related]
8. Immune response elicited in the tumor microenvironment upon rMV-SLAMblind cancer virotherapy.
Moritoh K; Shoji K; Amagai Y; Fujiyuki T; Sato H; Yoneda M; Kai C
Cancer Sci; 2023 May; 114(5):2158-2168. PubMed ID: 36715555
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic Activity of a Recombinant Measles Virus, Blind to Signaling Lymphocyte Activation Molecule, Against Colorectal Cancer Cells.
Amagai Y; Fujiyuki T; Yoneda M; Shoji K; Furukawa Y; Sato H; Kai C
Sci Rep; 2016 Apr; 6():24572. PubMed ID: 27090874
[TBL] [Abstract][Full Text] [Related]
10. Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
Bossow S; Grossardt C; Temme A; Leber MF; Sawall S; Rieber EP; Cattaneo R; von Kalle C; Ungerechts G
Cancer Gene Ther; 2011 Aug; 18(8):598-608. PubMed ID: 21701532
[TBL] [Abstract][Full Text] [Related]
11. Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo.
Künzi V; Oberholzer PA; Heinzerling L; Dummer R; Naim HY
J Invest Dermatol; 2006 Nov; 126(11):2525-32. PubMed ID: 16960554
[TBL] [Abstract][Full Text] [Related]
12. Measles Virus Enters Breast and Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway.
Delpeut S; Sisson G; Black KM; Richardson CD
J Virol; 2017 May; 91(10):. PubMed ID: 28250131
[TBL] [Abstract][Full Text] [Related]
13. Small molecules baicalein and cinnamaldehyde are potentiators of measles virus-induced breast cancer oncolysis.
Kuo YT; Liu CH; Wong SH; Pan YC; Lin LT
Phytomedicine; 2021 Aug; 89():153611. PubMed ID: 34144429
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines.
Kasloff SB; Pizzuto MS; Silic-Benussi M; Pavone S; Ciminale V; Capua I
J Virol; 2014 Aug; 88(16):9321-34. PubMed ID: 24899201
[TBL] [Abstract][Full Text] [Related]
15. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
[TBL] [Abstract][Full Text] [Related]
16. Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human neuroblastoma through a CD46 and nectin 4-independent pathway.
Zhang SC; Cai WS; Zhang Y; Jiang KL; Zhang KR; Wang WL
Cancer Lett; 2012 Dec; 325(2):227-37. PubMed ID: 22796607
[TBL] [Abstract][Full Text] [Related]
17. A recombinant measles virus vaccine strain rMV-Hu191 has oncolytic effect against human gastric cancer by inducing apoptotic cell death requiring integrity of lipid raft microdomains.
Lv Y; Zhou D; Hao XQ; Zhu MY; Zhang CD; Zhou DM; Wang JH; Liu RX; Wang YL; Gu WZ; Shen HQ; Chen X; Zhao ZY
Cancer Lett; 2019 Sep; 460():108-118. PubMed ID: 31226409
[TBL] [Abstract][Full Text] [Related]
18. The tumor-associated marker, PVRL4 (nectin-4), is the epithelial receptor for morbilliviruses.
Delpeut S; Noyce RS; Richardson CD
Viruses; 2014 Jun; 6(6):2268-86. PubMed ID: 24892636
[TBL] [Abstract][Full Text] [Related]
19. Measles vaccine strains for virotherapy of non-small-cell lung carcinoma.
Patel MR; Jacobson BA; Belgum H; Raza A; Sadiq A; Drees J; Wang H; Jay-Dixon J; Etchison R; Federspiel MJ; Russell SJ; Kratzke RA
J Thorac Oncol; 2014 Aug; 9(8):1101-10. PubMed ID: 25157763
[TBL] [Abstract][Full Text] [Related]
20. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
Blechacz B; Splinter PL; Greiner S; Myers R; Peng KW; Federspiel MJ; Russell SJ; LaRusso NF
Hepatology; 2006 Dec; 44(6):1465-77. PubMed ID: 17133484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]